TRI’s highly experienced Translational Trials team is dedicated to delivering highest-quality patient care and optimum project management for all phases of clinical trials, regardless of the complexity.
Prior to giving any new treatment to a human, it is extensively tested in laboratory trials to ensure it is not harmful.
Once thought to be safe, it is trialled in “healthy” people in a clinic or hospital setting to help determine the dose to be administered and check for unexpected side effects.
Testing is carried out on a larger number of patients over a longer period of time, sometimes in conjunction with a placebo to collate data about its safety and effectiveness.
Scaled up across multiple locations / populations with investment from Pharmaceutical companies to gather evidence for regulatory processes in readiness for commercialisation.
Equipped to support multi-phase adult clinical trials, the GCP aligned facilities include short stay rooms, onsite laboratory, exercise and nutrition facilities, and ready access to emergency response teams at the adjacent Princess Alexandra Hospital.
A purpose-built facility at the Queensland Children’s Hospital campus that provides a welcoming environment for families with children undergoing clinical trials. An onsite dedicated service team supports low-risk outpatient-based studies.
Worldwide, the limitation in realising the full potential of medical scientific discoveries was becoming apparent. Whilst Queensland had increased investment in discovery science by the late 1990s, there was a notable gap in clinical research and translational capacity.
TRI was conceived and advocated for by clinicians and administrators at the forefront of the Queensland healthcare system, largely based at the Princess Alexandra Hospital (PAH) in the early 2000’s. This was seen as an essential step in fast-tracking science into medicine – creating the ability to take concepts from the clinic to the bench, and ultimately back to the clinic in a greatly advanced form.
The PAH and people like Don Cameron, then Director of Diabetes and Endocrinology were very early believers in the concept of translation and played a leading role in the build-up to securing the construction of TRI on its campus.